10/12/2021 8:34:37 AM
Agenus To Receive $20 Mln Milestone Payment From Bristol Myers Squibb With Dosing Of First Patient For AGEN1777
6/17/2021 8:36:46 AM
FDA Accepts Agenus’ BLA For Balstilimab For The Treatment Of Recurrent Or Metastatic Cervical Cancer
4/14/2021 8:40:55 AM
Agenus Doses First Cancer Patient With AgenT-797 INKT Cell Therapy
2/9/2021 8:46:37 AM
Agenus Announces Addl Confirmed Objective Clinical Responses From Phase 1/2 Trial Of AGEN1181
3/16/2018 7:19:12 AM
William Blair Is Cutting Agenus Inc. (AGEN) 2021 Estimate To -1.31 From -1.02
3/16/2018 7:19:00 AM
William Blair Is Lowering Agenus Inc. (AGEN) 2020 Estimate To -1.40 From -1.23
3/16/2018 7:18:45 AM
William Blair Is Cutting Agenus Inc. (AGEN) 2019 Estimate To -1.39 From -1.33
3/16/2018 7:18:33 AM
William Blair Is Lowering Agenus Inc. (AGEN) 2018 Estimate To -1.44 From -1.37
3/16/2018 7:17:15 AM
William Blair Reiterates Agenus Inc. (AGEN) At Outperform
10/2/2017 10:22:06 AM
William Blair Reiterates Agenus Inc. (AGEN) At Outperform
3/4/2016 7:48:14 AM
William Blair Is Cutting Agenus Inc. (AGEN) 2017 Estimate To -0.98 From -0.66
3/4/2016 7:47:59 AM
William Blair Is Cutting Agenus Inc. (AGEN) 2016 Estimate To -0.81 From -0.64